Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Mar 2019
Comparative StudyIntrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Current imaging guidelines do not specify the preferred hepatobiliary contrast agent when differentiating hepatocellular adenoma (HCA) from focal nodular hyperplasia (FNH) on MRI. ⋯ 3 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2019;49:700-710.
-
J Magn Reson Imaging · Mar 2019
A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
Preoperative differentiation between primary sacral chordoma (SC), sacral giant cell tumor (SGCT), and sacral metastatic tumor (SMT) is important for treatment decisions. ⋯ 4 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:752-759.
-
J Magn Reson Imaging · Mar 2019
Quantitative Assessment of Regional Dynamic Airway Collapse in Neonates via Retrospectively Respiratory-Gated 1 H Ultrashort Echo Time MRI.
Neonatal dynamic tracheal collapse (tracheomalacia, TM) is a common and serious comorbidity in infants, particularly those with chronic lung disease of prematurity (bronchopulmonary dysplasia, BPD) or congenital airway or lung-related conditions such as congenital diaphragmatic hernia (CDH), but the underlying pathology, impact on clinical outcomes, and response to therapy are not well understood. There is a pressing clinical need for an accurate, objective, and safe assessment of neonatal TM. ⋯ 2 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2019;49:659-667.
-
J Magn Reson Imaging · Mar 2019
Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Accurate classification of gliomas is crucial for prescribing therapy and assessing the prognosis of patients. ⋯ 4 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:825-833.